ÌÇÐÄvlog´«Ã½

GI Stool Testing Market Analysis

The GI Stool Testing Market size is estimated at USD 507.52 million in 2024, and is expected to reach USD 696.67 million by 2029, growing at a CAGR of 6.54% during the forecast period (2024-2029).

Factors such as the growing burden of gastrointestinal diseases and rising preference for point-of-care tests are boosting the market growth.

In recent years, the rate of diagnosis for gastrointestinal infections has increased, propelling the market's growth. For instance, according to a report published by the Bower Cancer UK in February 2024 showed that bowel cancer is the fourth most common cancer, and approximately 43,000 people are diagnosed with bowel cancer every year in the United Kingdom. This is expected to increase the demand for stool DNA testing, which is used to screen for colon cancer in people with no symptoms, propelling the market growth.

Additionally, according to a report published by the Cureus Journal in January 2024, globally, hemorrhoids affect approximately 50% to 85% of the population, impacting individuals of all genders and across all age groups. Moreover, the report mentioned that in Northwest Ethiopia, 13.1% of patients visiting the surgical outpatient department were affected by hemorrhoids. The risk of having hemorrhoids was shown to be higher in people who were overweight and had constipation problems. Thus, the high prevalence of hemorrhoids among the population is anticipated to increase the need for a fecal occult blood test to detect the disease and hence boost the market growth early.

Also, the rising product launches increase the availability of stool testing kits and products in the market, which is anticipated to fuel market growth. For instance, in June 2022, Prenetics Group Limited, one of the global leaders in genomic and diagnostic testing, launched a novel, non-invasive, at-home screening test, ColoClear by Circle (ColoClear), for detecting early signs of colorectal cancer in Hong Kong.

Therefore, the market is expected to grow during the forecast period due to the high burden of gastric cancer and other related diseases. However, the high cost of instruments is expected to impede the growth of the GI stool testing market during the forecast period.

GI Stool Testing Industry Segmentation

As per the scope of the report, gastrointestinal infection testing involves the detection and analysis of any pathogens in the digestive tract using the stool as a sample. The gastrointestinal infection testing market is segmented by product type, test type, and geography. The product type segment is further segmented into instrument and reagent. The test type segment is further divided into occult blood test, ova and parasites test, bacteria test, fecal biomarkers test, and other test types. By geography, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and South America. The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD) for the above segments.